Pancakes or eggs? 🥞🍳 Dr. Alejandro Berlin shares a memorable analogy for counseling patients on localized prostate cancer treatments and balancing side-effect profiles. Ep 44 of The View on GU with @LalaniMD and @WallisCJD is now live at https://t.co/eP9NFPfHSa. #ProstateCancer
Don’t do it alone. Keep going despite failures. Recognize the role luck can play in success. Three lessons that guest Dr. Neil Fleshner shares with @LalaniMD and @WallisCJD on pursuing medical entrepreneurship and much more at https://t.co/kSQYsytayu
Having the right people around you is crucial for building a business. In Episode 34, Dr. Neil Fleshner shares how each of his POINT Biopharma co-founders brought something unique to grow the business and fuel its success: https://t.co/kSQYsytayu
Can you thrive in both medicine and entrepreneurship? Dr. Neil Fleshner joins Dr. @LalaniMD & Dr. @WallisCJD to discuss balancing a career as an academic surgeon with scaling several successful healthcare businesses: https://t.co/xipk6Ukova
Good mentorship is not about creating a copy of yourself. In Episode 33 of The View on GU, Dr. Daniel Heng discusses listening to a mentee’s goals, recognizing when interests don't align, and connecting trainees with people who can best support them: https://t.co/H9vKDZ9sPQ
Build momentum now while investing in the bigger questions. In Episode 33 of The View on GU, Dr. Daniel Heng shares how balancing immediate database research with long-term clinical trials helped shape his career and the global IMDC collaboration: https://t.co/H9vKDZ9sPQ
Before the academic year & mentorship activities ramp back up this fall, time to get inspired! Watch Episode 33 of The View on GU, where Drs. @LalaniMD & @WallisCJD sit down with @DrDanielHeng to explore the power of #mentorship in medicine: https://t.co/JkBLV6bggF
The EV-302 trial revolutionized bladder cancer care. But what happens over the long term? In Episode 43, Dr. @LalaniMD shares crucial updates on the EVP combination and discusses the newest updates from @ASCO. Catch up on the full #ASCO26 series now: https://t.co/xipk6Ukova
In Episode 42, Dr. @WallisCJD breaks down a major detail in the RAMPART trial presented at #ASCO26: a quarter of the patients had early-stage disease that would've kept them out of other landmark trials. Full conversation in our @ASCO recap series: https://t.co/xipk6Ukova
In Episode 41, Dr. @LalaniMD & Dr. @WallisCJD discuss the logistical realities of the TALAPRO-3 & PROTEUS trials. As advanced genetic testing and new imaging tools become standard, how clinicians coordinate patient care may need to change: https://t.co/xipk6Ukova
🚨OUT NOW: Join Dr. @LalaniMD & Dr. @WallisCJD for their recap of #ASCO26! In this three-episode series, they break down key updates in GU oncology, including the PROTEUS trial design. Catch the entire @ASCO recap series now: https://t.co/xipk6Ukova
We’re back from the Windy City & can’t wait to share with you everything we heard at the @ASCO 2026 Annual Meeting! ✈️ Join us tomorrow as we release 3 episodes reviewing the latest in prostate, kidney & bladder cancer. Learn more: https://t.co/xipk6Ukova @LalaniMD@WallisCJD
In Episode 40, Dr. Girish Kulkarni (@GSK_UofT) shares why the "surgery-first" approach for MIBC is rapidly changing by diving into EV-303 & EV-304 data. Watch or listen to our newest series now to learn how it's shifting the standard of care: https://t.co/xipk6Ukova
In Ep 39, Dr. Girish Kulkarni (@GSK_UofT), Dr. @LalaniMD & Dr. @WallisCJD discuss the balance of NMIBC treatment & bladder preservation. Watch or listen now to hear Dr. Kulkarni’s perspective on how to find the right therapeutic fit for each patient: https://t.co/xipk6Ukova
We’re kicking off #BladderCancerAwarenessMonth with a new series featuring Dr. Girish Kulkarni (@GSK_UofT). Released today, it covers everything from NMIBC & MIBC to advanced urothelial cancer, with a focus on the "how-to" of BCG therapy at https://t.co/xipk6Ukova
May is #BladderCancerAwarenessMonth, & we are thrilled to welcome a leading expert in the #BladderCancer space for two special episodes: Dr. Girish Kulkarni (@GSK_UofT)! On May 11, Dr. Kulkarni will join us to discuss NMIBC, MIBC, & advanced urothelial cancer. We’ll see you then!
🩸In our newest episode, Dr. @ResearchWyatt explains why ctDNA liquid biopsies are a game-changer for #ProstateCancer care, providing powerful insights for genotyping the disease. Dr. Wyatt’s full conversation with Dr. @LalaniMD and Dr. @WallisCJD now: https://t.co/xipk6Ukova
With so many options in #Genomics, how do you balance everything that could be tested with what’s useful in clinical practice? Dr. @ResearchWyatt joins Dr. @LalaniMD and Dr. @WallisCJD to discuss the real-world use of genomic testing in GU cancers: https://t.co/xipk6Ukova
📚 Class is in session! Our newest episode “Genomics 101 in GU Cancers” just dropped, featuring Dr. @ResearchWyatt from @ubc & @VanProstateCtr. In Episode 38, he kicks things off by breaking down the core concepts of #Genomics. Watch or listen now! https://t.co/xipk6Ukova
On April 23, Dr. @LalaniMD and Dr. @WallisCJD are diving into Genomics 101 for GU cancers with Dr. @ResearchWyatt.
From @ubc, @VanProstateCtr and BC Cancer, Dr. Wyatt’s research is advancing how we understand and treat prostate and bladder cancers. We'll see you Thursday!